Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection

BACKGROUND: Children with perinatally acquired HIV (paHIV) remain at an increased risk of pneumococcal infection despite highly active antiretroviral therapy (HAART). Beyond infancy, responses to pneumococcal conjugate vaccine (PCV) remain under-investigated. There are currently no published data on serological response to 13-valent PCV (PCV13) in the HIV-infected populations. METHODS: We measured pneumococcal serotype-specific IgG in 48 paHIV-infected child patients (CP), 27 young adult healthy controls (AHC) and 30 child healthy controls (CHC). Opsonophagocytic assay (OPA) titres for three PCV13-exclusive serotypes were measured in a subset of children. Serotype-specific IgG was repeated 1 and 6 months following PCV13 vaccination of CP and AHC groups. OPA titres for four serotypes were measured at the 1-month time-point. RESULTS: The majority of CP, CHC and AHC had serotype-specific IgG above 0.35 μg/ml at baseline, although OPA activity was undetectable for two of the three serotypes studied. Baseline IgG concentrations were significantly lower in CP than AHC for a proportion of serotypes and were strongly predictive of responses to vaccine. After adjusting for baseline, postvaccination IgG concentrations were comparable, although responses to some serotypes were impaired for CP. OPA correlated well with IgG after vaccination. Detectable HIV viral load was associated with significantly lower IgG concentration and OPA titre. CONCLUSION: Children with paHIV mount a robust serological response to PCV13 for most but not all vaccine serotypes. Viral load suppression with HAART and higher baseline IgG concentration are associated with higher postvaccination antibody levels. This has implications for HAART treatment and vaccination practices

Stem cells and their role in pituitary tumorigenesis

The presence of adult pituitary stem cells (PSCs) has been described in murine systems by comprehensive cellular profiling and genetic lineage tracing experiments. PSCs are thought to maintain multipotent capacity throughout life and give rise to all hormone-producing cell lineages, playing a role in pituitary gland homeostasis. Additionally, PSCs have been proposed to play a role in pituitary tumorigenesis, in both adenomas and adamantinomatous craniopharyngiomas. In this manuscript, we discuss the different approaches used to demonstrate the presence of PSCs in the murine adult pituitary, from marker analyses to genetic tracing. In addition, we review the published literature suggesting the existence of tumor stem cells in mouse and human pituitary tumors. Finally, we discuss the potential role of PSCs in pituitary tumorigenesis in the context of current models of carcinogenesis and present evidence showing that in contrast to pituitary adenoma, which follows a classical cancer stem cell paradigm, a novel mechanism has been revealed for paracrine, non-cell autonomous tumor initiation in adamantinomatous craniopharyngioma, a benign but clinically aggressive pediatric tumor

Cell organization in soft media due to active mechanosensing

Adhering cells actively probe the mechanical properties of their environment and use the resulting information to position and orient themselves. We show that a large body of experimental observations can be consistently explained from one unifying principle, namely that cells strengthen contacts and cytoskeleton in the direction of large effective stiffness. Using linear elasticity theory to model the extracellular environment, we calculate optimal cell organization for several situations of interest and find excellent agreement with experiments for fibroblasts, both on elastic substrates and in collagen gels: cells orient in the direction of external tensile strain, they orient parallel and normal to free and clamped surfaces, respectively, and they interact elastically to form strings. Our method can be applied for rational design of tissue equivalents. Moreover our results indicate that the concept of contact guidance has to be reevaluated. We also suggest that cell-matrix contacts are upregulated by large effective stiffness in the environment because in this way, build-up of force is more efficient.Comment: Revtex, 7 pages, 4 Postscript files include

HIT vs. LSD: Four Days of Intensive Training does not Influence Lactoferrin, but LSD Increases Resting IL-6 while Attenuating the Acute Exercise Response, yet HIT Elevates Salivary Cortisol Levels

High intensity training programs (HIT) induce comparable endurance performance adaptations to those of continuous long slow distance training (LSD). HIT has increased, as athletes are able to maintain their VO2 max or performance with less time, and reduced training volume. High training volume may be immunosuppressive. PURPOSE: To examine a major mucosal immune component (salivary lactoferrin), the circulating cytokines (IL-6, IL-8, TNF-α), and cortisol response to HIT and LSD during 4 days of intensified training (IT). METHODS: Eight endurance-trained males (23.1±2.0yr,VO2 max 53.9±5.3 ml×kg-1×min-1) performed two, 4-day IT protocols: HIT and LSD conditions (separated by ³ 21 days). Both conditions included 2 exercise sessions / day (morning (AM) and late afternoon (PM)). LSD consisted of 50 min cycle ergometery in the AM (70% VO2max) and 90 min running in the PM (70% VO2max). The AM HIT session included 8 all-out, 30 sec cycling sprints (resistance=0.075kg×kg-1 body mass) with 4.5-8.5 min active recovery. The PM HIT session was the same as that for LSD. Blood and saliva samples were obtained at various time points based on the dependent variable. Plasma cytokines and creatine kinase (CK) activity were assessed both before and after the AM exercise sessions (pre-(PR), post(PO)-exercise) in both conditions on the first (before training; BT) and fourth (after training; AT) day of IT. Creatine kinase activity and cytokines were assessed in plasma. Salivary lactoferrin, and cortisol were assessed at 3 time points on days 1, 2 and 4 (PR and PO for AM, and PR for PM) in UHIT and LSD. Additionally, saliva was also collected at one time point (PR for the AM session) on the third and fifth day. RESULTS: Values above are listed as IL-6 (pg·mL-1), CK (U/L). BT= Day 1, AT= Day 4. Same letters indicate differences between time points for IL-6 serum levels (p\u3c0.05). Same numbers indicate differences between time points for CK activity (p\u3c0.05). Additionally, a significant time x day interaction occurred for lactoferrin secretion rate (PO\u3ePR on days 1 and 4, 1735\u3e5639 and 2290\u3e5663 ng·min-1, respectively; p=0.032). Moreover, a significant condition x time interaction occurred for lactoferrin secretion rate (p=0.047). A main effect for condition revealed that salivary cortisol was greater in HIT vs. LSD (p=0.028). CONCLUSION: Four days of IT did not attenuate the lactoferrin response to acute exercisese. LSD resulted in elevated resting IL-6, which may be responsible for the attenuation of the IL-6 response to acute exercise in this condition due to a feedback inhibition mechanism. Cortisol response is frequently linked to that of Il-6. Il-6 response to acute exercise was maintained in HIT, which may explain the elevated cortisol levels

The Influence of Physical Activity on Monocyte Phenotype on Circulating Platelet-Monocyte Complexes in Overweight/Obese Persons

Elevated platelet-monocyte complexes (PMC) promote atherosclerosis and are associated with cardiovascular disease. It is unknown whether consistent physical activity (PA) decreases circulating PMCs. Additionally, no one has determined the monocyte phenotype most associated with PMCs. Purposes: 1) to examine the influence of PA on PMCs and their association with inflammatory /prothrombotic markers such as C-reactive protein (CRP), L-selectin (LS), platelet factor 4 (PF4), von Willebrand Factor (vWF), and hemoglobin A1C (HbA1c) and 2) to determine the monocyte phenotype most likely to form PMCs. Methods: Thirty-one overweight/obese subjects (44±5yr, BMI 34.2±5 kg×m2) were divided into two groups: sedentary (SED, n=17) and physically active (PA, n=14) based on physical activity logs. SED participated in \u3c 1 h of formal exercise while PA participated in moderate-high intensity exercise at least 3 h per week. Flow cytometry was used to identify PMCs on the monocyte phenotypes: classical (CD14+CD16-), intermediate (CD14+CD16+), and non-classical (CD14+CD16++). Platelets were identified using the marker CD42a. Results: Percentage of circulating PMCs and median fluorescence intensity of CD42a (MedFI; marker of platelet density per monocyte) were not different between groups; however, monocyte phenotype significantly impacted PMC percentage and MedFI where the lower the CD16 expression, the greater the adhesion of platelets. Classical monocytes (CD16-) had the highest % of PMC, etc. (Fig 1). HbA1c was greater (p=0.031) and LS (p=0.019) was lower in SED compared to PA (Fig. 2). There were no significant associations between any blood marker and PMC percentage, but PF4 was correlated with percent of CD16 -(r= -0.482, p=0.031) and CD16+(r= 0.473, p=0.035) monocytes. Conclusions: The absence of a separation between groups in VO2max may partially explain the lack of a difference in PMCs between groups. Regarding our second aim, classical monocytes appear to be more involved in PMC formation than do CD16+ monocytes with CD16++ having the lowest percentage of cells with platelets adhered (PMC). This observation may be due to the shedding of adhesion molecules from platelets and monocytes during activation from classical (CD16-) to a more inflammatory state (ie. CD16+)

Investigation of the Tumour Promoting Effects of Cellular Senescence During Pituitary and Lung Tumourigenesis

This thesis involves understanding the role that cellular senescence plays during the early stages of adamantinomatous craniopharyngioma (ACP) and non-small cell lung cancer (NSCLC) tumourigenesis using genetically engineered mouse models. The host laboratory has previously shown that when pituitary stem cells are targeted with oncogenic β-catenin, they form clusters of stem cells that show non-cell autonomous tumour inducing potential. Using immunohistochemical and transcriptomic approaches, here I show that cluster cells are molecularly analogous in mouse and human ACP and share a signature of senescence with concomitant activation of the senescence associated secretory phenotype (SASP). I reveal that the tumour-inducing potential of the cluster cells requires a robust SASP. This is evidenced by targeting pituitary stem cells of aged mice (older than 6 months) with oncogenic β -catenin, which results in reduced SASP and decreased tumourigenesis. This suggests that a robust SASP is the likely driver of paracrine tumourigenesis in the pituitary. Further to this, the role of activated MAPK signalling during pituitary development was explored by driving the expression of oncogenic Kras (KrasG12D) and Braf (BrafV600E) in either pituitary progenitors or postnatal adult pituitary stem cells. By demonstrating a cell-autonomous expansion of the embryonic pituitary stem cells compartment with impaired differentiation potential, this study provided insight into the pathogenesis of another pituitary tumour, papillary craniopharyngioma. Finally, during oncogenic Kras-driven (KrasG12D) NSCLC progression in mice, it is observed that the adenoma phase of the tumour does not show a high level of senescence, however senescent cells are found outside and in association with the growing tumours in agreement with the concept of paracrine senescence. To study these senescent cells in vivo a new genetically engineered mouse model (p16FDR) was developed which allows for their visualisation, pharmacogenetic ablation and lineage tracing. Ablation of these senescent cells using p16FDR mice was found to reduce tumour burden and proliferation significantly. Together, these data suggest that senescence can have paracrine pro-tumourigenic properties and their therapeutic ablation may be clinically beneficial

Hot Topic: Interest Rate Set at 7.25 Percent Effective July 1, 2011, on Delinquent Taxes Collected or Administered by the State of Tennessee

The rate of interest effective July 1, 2011, through June 30, 2012, has been set at 7.25 percent, which is the same as for the current year (FY 2011)

Hot Topic: Interest Rate Set at 7.25 Percent Effective July 1, 2010, on Delinquent Taxes Collected or Administered by the State of Tennessee

The rate of interest effective July 1, 2010, through June 30, 2011, has been set at 7.25 percent, which is the same as for the current year (FY 2011)